Transcripts FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
21.53 ^USD	+0.09%		+0.47%	+124.04%

May. 09	Fusion Pharmaceuticals Inc. Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer	CI
May. 07	Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Fusion Pharmaceuticals Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 03:35 PM	23-09-13
Transcript : Fusion Pharmaceuticals Inc. - Special Call	23-06-27
Transcript : Fusion Pharmaceuticals Inc. Presents at Guggenheim Healthcare Talks Radiopharmaceuticals Day, May-15-2023 10:10 AM	23-05-15
Transcript : Fusion Pharmaceuticals Inc. - Special Call	23-02-13
Transcript : Fusion Pharmaceuticals Inc. Presents at B. Riley Securities' 3rd Annual Oncology Conference, Jan-18-2023 through Jan-19-2023	23-01-18
Transcript : Fusion Pharmaceuticals Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-14-2022 12:55 PM	22-09-14
Transcript : Fusion Pharmaceuticals Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 11:00 AM	21-09-09
Transcript : Fusion Pharmaceuticals Inc. - Special Call	20-11-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW